Inhibins and Activins

Inhibins and activins are dimeric protein hormones belonging to the transforming growth factor-beta (TGF-β) superfamily. They play crucial roles in the regulation of reproductive physiology by modulating the secretion of follicle-stimulating hormone (FSH) from the anterior pituitary gland. Inhibins primarily suppress FSH secretion, while activins stimulate it, thus maintaining a delicate balance in the hypothalamic-pituitary-gonadal (HPG) axis. Beyond their endocrine functions, both inhibins and activins are involved in paracrine and autocrine signaling within the gonads and other tissues, influencing processes such as cell proliferation, differentiation, and apoptosis.

Molecular Structure and Isoforms

Inhibins

Inhibins are heterodimeric glycoproteins composed of one alpha (α) subunit and one beta (β) subunit. There are two main forms:

• Inhibin A: Composed of the α-subunit and the βA-subunit.
• Inhibin B: Composed of the α-subunit and the βB-subunit.

The α-subunit is unique to inhibins, while the β-subunits are shared with activins. The alpha subunit confers the inhibitory function, allowing inhibins to antagonize activin signaling.

Activins

Activins are homodimers or heterodimers made up of beta subunits only:

• Activin A: βA-βA homodimer.
• Activin B: βB-βB homodimer.
• Activin AB: βA-βB heterodimer.

Activins lack the α-subunit and thus have distinct functional properties from inhibins, primarily stimulating FSH release and promoting diverse cellular responses.

Subunit Genes and Protein Synthesis

The α-subunit is encoded by the INHA gene, while βA and βB are encoded by INHBA and INHBB genes, respectively. These subunits are synthesized as precursor proteins containing signal peptides that direct secretion and undergo post-translational modifications, including cleavage and glycosylation, before forming mature dimers.

Physiological Roles

Regulation of the Hypothalamic-Pituitary-Gonadal Axis

• Inhibins: Secreted mainly by granulosa cells in the ovary and Sertoli cells in the testis, inhibins selectively inhibit FSH synthesis and secretion at the pituitary level without affecting luteinizing hormone (LH). This negative feedback regulates follicular development and spermatogenesis by modulating FSH availability.

• Activins: Produced locally within the pituitary and gonads, activins enhance FSH synthesis and secretion by increasing expression of the FSH β-subunit gene. Activins also stimulate pituitary cell proliferation and sensitize gonadotropes to gonadotropin-releasing hormone (GnRH).

Gonadal Functions

• Inhibins and activins act locally within the gonads to regulate folliculogenesis, steroidogenesis, and gametogenesis.
• Activins stimulate granulosa cell proliferation and promote the synthesis of steroidogenic enzymes.
• Inhibins antagonize activin effects, contributing to the selection and dominance of ovarian follicles.
• In males, inhibins inhibit FSH to regulate Sertoli cell function and spermatogenesis, while activins promote proliferation of Sertoli cells and Leydig cell steroidogenesis.

Extra-Gonadal Actions

Both inhibins and activins exert biological effects beyond the reproductive system:

• Influencing bone metabolism by regulating osteoblast and osteoclast activities.
• Modulating immune responses through effects on cytokine production and immune cell function.
• Affecting tissue repair and fibrosis by regulating cell growth and extracellular matrix production.

Mechanisms of Action

Receptor Binding and Signal Transduction

• Activin Signaling: Activins bind to a complex of type II and type I serine/threonine kinase receptors on target cells. The type II receptor recruits and phosphorylates the type I receptor, which then phosphorylates SMAD2 and SMAD3 intracellular proteins. These SMADs form complexes with SMAD4 and translocate to the nucleus to regulate gene transcription.

• Inhibin Antagonism: Inhibins inhibit activin signaling primarily by binding to the activin type II receptors with the assistance of a co-receptor, betaglycan (also called TGF-β type III receptor). This prevents activin from binding and activating its receptor complex, thus blocking downstream SMAD signaling.

Modulation of FSH Synthesis

• Activins upregulate FSH β-subunit gene transcription by enhancing promoter activity through SMAD-dependent mechanisms.
• Inhibins counteract this effect by preventing activin receptor activation, reducing SMAD phosphorylation, and thus decreasing FSH β-subunit expression.

Clinical Significance

Biomarkers in Reproductive Medicine

• Serum levels of inhibin A and B serve as markers for ovarian follicular activity and are used in evaluating ovarian reserve, predicting response to controlled ovarian stimulation, and diagnosing ovarian tumors.
• Inhibin B is particularly useful in assessing Sertoli cell function and spermatogenic capacity in men.
• Activin levels have been investigated as indicators of reproductive and non-reproductive pathologies, though their clinical utility is less established than inhibins.

Pathophysiology

• Dysregulation of inhibin and activin signaling has been implicated in reproductive disorders such as polycystic ovary syndrome (PCOS), premature ovarian failure, and infertility.
• Activin overexpression is associated with certain cancers, including ovarian, prostate, and breast cancers, where it may influence tumor progression by modulating cell proliferation and apoptosis.
• Inhibin deficiency or mutations can lead to reproductive dysfunctions and gonadal tumors.

Therapeutic Applications

• Modulating inhibin and activin pathways offers potential therapeutic approaches for infertility, hormone-dependent cancers, and fibrotic diseases.
• Recombinant inhibins and activins or their antagonists are being explored experimentally to regulate FSH secretion and influence reproductive outcomes.

Summary Table of Inhibins and Activins

This comprehensive overview elucidates the molecular characteristics, physiological roles, mechanisms of action, and clinical relevance of inhibins and activins, highlighting their central role in reproductive endocrinology and beyond.